Coriell: Patient genome info to be included in EMRs
Biomedical research institution Coriell Institute for Medical Research has partnered with Ohio State University (OSU) Medical Center physicians to incorporate genetic risk information into their patients' EMRs, through their participation in the Coriell Personalized Medicine Collaborative (CPMC) research study. The goal of the CPMC study is to understand the utility of genome information in patient care and develop best practices for the field.
The collaboration involves 30 to 35 Columbus-based OSU cardiologists and primary care physicians and 1,800 of their patients who have been diagnosed with congestive heart failure or hypertension, according to the Coriell Institute, based in Camden, N.J. The patients' genomic information will be entered into their EMRs and observations will be made as to how their physicians use the personalized genetic risk information to make clinical care decisions.
The study will reveal whether genome-informed medicine has utility in practice, and how likely doctors are to use the information when it is made available to them, Coriell stated.
In addition to monitoring physician behavior and knowledge, the impact of genetic counseling on patient behaviors will also be studied.
Participants will be asked to complete a series of surveys regarding the understanding of their risk, knowledge of genetics, what they did after learning of their personalized risk information, and with whom they shared their results, according to the institute.
The collaboration involves 30 to 35 Columbus-based OSU cardiologists and primary care physicians and 1,800 of their patients who have been diagnosed with congestive heart failure or hypertension, according to the Coriell Institute, based in Camden, N.J. The patients' genomic information will be entered into their EMRs and observations will be made as to how their physicians use the personalized genetic risk information to make clinical care decisions.
The study will reveal whether genome-informed medicine has utility in practice, and how likely doctors are to use the information when it is made available to them, Coriell stated.
In addition to monitoring physician behavior and knowledge, the impact of genetic counseling on patient behaviors will also be studied.
Participants will be asked to complete a series of surveys regarding the understanding of their risk, knowledge of genetics, what they did after learning of their personalized risk information, and with whom they shared their results, according to the institute.